Skip to main content
. 2018 Jan 9;9(6):6691–6706. doi: 10.18632/oncotarget.24068

Table 2. Comparison of laboratory findings between iMCD and IgG4-RD.

iMCD
(n=22)
IgG4-RD
(n=26)
p-value
IgG
 Concentrations (mg/dL)* 4,782 (811-31,313) 2,098 (1,150-4,661) <0.001
 >1x ULN (n, %) 19 (86%) 20 (77%) 0.478
 >2x ULN (n, %) 16 (73%) 5 (19%) <0.001
IgG4
 Concentrations (mg/dL)* 483 (50-1,230) 611 (146-2,140) 0.270
 >1x ULN (n, %) 14 (88%) 26 (100%) 0.139
 >2x ULN (n, %) 12 (75%) 21 (81%) 0.956
IgG4/IgG ratio
 Ratio (%) 8.6 (1.5-23.6) 24.1 (8.7-59.0) <0.001
 >5% (n, %) 12 (75%) 26 (100%) 0.016
 >10% (n, %) 5 (31%) 25 (96%) <0.001
CRP
 Concentrations (mg/dL)* 6.7 (1-50.4) 0.1 (0-1.25) <0.001
 >1x ULN (n, %) 22 (100%) 5 (19%) <0.001
 >5x ULN (n, %) 20 (91%) 0 <0.001
Hemoglobin (g/dL)
 Concentration (g/dL)* 9.9 (6.6-13.4) 13.6 (9.6-15.5) <0.001
 <1x LLN (n, %) 21 (95%) 10 (38%) <0.001
IL-6 (pg/mL)
 Concentration (pg/mL)* 21.6 (4-76) NA NA
 >1x ULN (n, %) 19 (95%) NA NA

ULN, the upper limit of normal; LLN, the lower limit of normal; *, data are shown as a median (range); , data available in 16 cases; , data available in 20 cases. Normal ranges: IgG, 870-1,700 mg/dL; IgG4, <135 mg/dL; CRP, 0-0.3 mg/dL; hemoglobin, 11.8-15.0 g/dL (female), 13.6-17.0 g/dL (male); IL-6, 0-4 pg/mL.